Skip to Main Content
Pharmacist's Letter Canada
Menu
    • Products
      • Hospital Pharmacist's Letter
      • Hospital Pharmacy Technician's Letter
      • Learning Management Portal
      • Natural Medicines
      • Pharmacist's Letter
      • Pharmacist's Letter Canada
      • Pharmacy Technician's Letter
      • Pharmacy Technician's Letter Canada
      • Prescriber's Letter
      • RxAdvanced
      • RxSelect

    Subscribe Login
  • Home
  • Letter
    • Current Issue
    • Past Issues
    • Suggest a Topic
  • Browse
    • Subject
    • Charts
    • Natural Medicines Resources
  • New Drugs
  • Help
    • User Support
    • Contact Us
  • Go To CE/CME & Training

Upgrade Your Browser

We no longer support this version of your browser. We recommend that you upgrade to the latest version of Internet Explorer, Firefox, Chrome or Safari to improve your security and experience using this website.

Return to the course you were viewing

  1. Home
  2. Browse
  3. Psychiatry
  4. Resources
  5. Drugs

Drugs

  • ADHD (61)
  • Agitation (1)
  • Anxiety (29)
  • Bipolar Disorder (11)
  • Depression (244)
  • Mental Health (22)
  • Psychology (2)
  • Resources (132)
    • Charts (34)
    • Drugs (47)
      • Anti-Anxiety Drugs (5)
      • Antidepressants (21)
      • Antipsychotics (29)
      • Mood Stabilizers (4)
    • Guidelines (22)
    • Patient Education (9)
    • PL Voices (43)
    • Quality Measures (3)
  • Schizophrenia (54)
  • Sleep Disorders (82)
  • Substance Use Disorder (178)
31 - 45 of 47 Results
Sort Results:
  • Title: Ascending (A-Z)
  • Date: Newest First
  • Date: Oldest First
Article: Have an "Exit Plan" for Antipsychotics in Dementia Patients June 2017
Article: Explain Antidepressants Don't Worsen OPEN-Angle Glaucoma November 2016
Commentary: Antidepressant Use and the Risk of Glaucoma November 2016
Article: Think of Invega Trinza as the Longer-Acting Version of Invega Sustenna October 2016
Article: Recommend Monitoring Blood Pressure With the New Antidepressant Fetzima August 2016
Article: Suggest Reducing Parkinson's Meds that Might be Contributing to Psychosis August 2016
Commentary: New Drug: Fetzima (Levomilnacipran) August 2016
Other: Managing Depression in Adults August 2016
Technician Tutorial: Depression 101 August 2016
FAQ: Parkinson’s Dementia and Dementia With Lewy Bodies August 2016
PL Voices: Improving Outcomes in Patients with Depression March 2016
Article: Be Aware that Abilify is Linked to Uncontrollable Gambling and Hypersexuality January 2016
Other: Aripiprazole (Abilify) and Risk of Impulse Control Behaviors January 2016
Article: Discourage Atypical Antipsychotics for Insomnia or Dementia July 2015
Article: Abilify Maintena (aripiprazole) will be another intramuscular long-acting atypical antipsychotic option May 2014
  • « Prev
  • 1
  • 2
  • 3
  • 4
  • Next »
  • About Us
  • Our Mission
  • Our Team
  • Testimonials
  • Careers
  • Newsroom
  • Products
  • Pharmacist Solutions
  • Prescriber Solutions
  • Hospital Solutions
  • Retail Solutions
  • Group Practice Solutions
  • Support & Policies
  • Contact Us
  • Access Agreement
  • Privacy Policy

The contents of this website are not intended to be a substitute for professional medical advice, diagnosis, or treatment. See additional information.

© Therapeutic Research Center. All Rights Reserved